ACAD vs TRV · P/E 15, rev $576.0M vs P/E 14, rev $12.15B
ACADIA Pharmaceuticals Inc (ACAD) versus The Travelers Companies Inc (TRV) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
The Travelers Companies Inc (TRV) is a insurance - property & casualty company listed on US.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported TRV revenue for 2026-06-30 was $12.15B. Net income was $2.21B. Revenue was up 1.9% from 2026-03-31 to 2026-06-30. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
Not investment advice. Open the ACAD and TRV stock pages for the full models.
Not investment advice.